ViiV Healthcare’s new HIV medicine TivicayTM (dolutegravir) is approved in Europe

ViiV Healthcare today announced that the European Commission has approved TivicayTM (dolutegravir).

Source: GSK news - January 21, 2014 Category: Pharmaceuticals Source Type: news